{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:48:30Z","timestamp":1782121710982,"version":"3.54.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    Breast cancer is a prevalent malignancy among women worldwide. Understanding its molecular mechanisms is crucial for prevention, early diagnosis, and treatment. Using a dataset of intraoperative radiotherapy (IORT) for breast cancer, we analyzed 21 breast tissue samples from patients who received IORT and 16 samples from those who did not. Principal component analysis was employed to reveal data structure, and differentially expressed genes (DEGs) were identified. We constructed a gene network using weighted gene co-expression network analysis and conducted functional enrichment analysis and gene set enrichment analysis. Immune infiltration analysis and protein-protein interaction network analysis were performed, resulting in gene expression heatmaps and Comparative Toxicogenomics Database analysis. Finally, regulatory microRNAs (miRNA) for core genes were predicted using miRNA prediction websites. A total of 2774 DEGs were identified. Principal component analysis demonstrated the differentiation between IORT and non-IORT samples. DEGs were enriched in key biological processes, such as T-cell receptor signaling, immunological synapse formation, and apoptosis. Gene set enrichment analysis validated the functional enrichment of DEGs. Weighted gene co-expression network analysis constructed 15 modules and identified hub genes. Protein-protein interaction network analysis revealed 4 core genes (\n                    <jats:italic toggle=\"yes\">CD2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CD3D<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CD3G<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">CD3E<\/jats:italic>\n                    ). miRNA prediction identified regulatory miRNAs for these core genes. Comparative Toxicogenomics Database analysis revealed that these core genes are associated with breast tumors and inflammation. Immune infiltration analysis showed a high proportion of Macrophages M0 and Macrophages M2 in the samples and revealed correlations between T cells and neutrophils. These findings suggest that the core genes may play key roles in the pathological changes and immune regulation of breast cancer tissues.\n                    <jats:italic toggle=\"yes\">CD2<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">CD3D<\/jats:italic>\n                    may serve as potential immune-related biomarkers for IORT in the treatment of breast cancer, influencing tissue pathological changes in breast cancer patients by regulating immune responses and cell signaling pathways.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048367","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:00:11Z","timestamp":1777629611000},"page":"e48367","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploration of CD2 and CD3D as potential immune-related biomarkers for IORT in breast cancer treatment"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4138-566X","authenticated-orcid":false,"given":"Shenglan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3264-9212","authenticated-orcid":false,"given":"Yubing","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Geriatric Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-544X","authenticated-orcid":false,"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Diagnosis, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20260622","first-page":"17","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molonc.2010.04.011","article-title":"Genetic susceptibility to breast cancer.","volume":"4","author":"Mavaddat","year":"2010","journal-title":"Mol Oncol"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2.","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers.","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.","volume":"50","author":"Bubien","year":"2013","journal-title":"J Med Genet"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2.","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1023\/A:1011609401132","article-title":"Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer.","volume":"12","author":"Vaidya","year":"2001","journal-title":"Ann Oncol"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT - a randomised trial.","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10549-010-1115-5","article-title":"Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.","volume":"124","author":"Veronesi","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-anchem-062012-092628","article-title":"Next-generation sequencing platforms.","volume":"6","author":"Mardis","year":"2013","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer.","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20260622","first-page":"7","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer.","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"20 Pt 2","key":"R17-20260622","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity.","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes.","volume":"28","author":"Kennecke","year":"2010","journal-title":"J Clin Oncol"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.hemonc.2021.02.002","article-title":"Molecular mediators of breast cancer metastasis.","volume":"14","author":"Yeeravalli","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2009.02.039","article-title":"Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial.","volume":"76","author":"Lemanski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2782-9","article-title":"Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.","volume":"143","author":"Alvarado","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.coi.2006.05.017","article-title":"T cell-dendritic cell immunological synapses.","volume":"18","author":"Dustin","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"eabn6373","DOI":"10.1126\/sciimmunol.abn6373","article-title":"Cis interactions between CD2 and its ligands on T cells are required for T cell activation.","volume":"7","author":"Li","year":"2022","journal-title":"Sci Immunol"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"705260","DOI":"10.3389\/fimmu.2021.705260","article-title":"CD58 immunobiology at a glance.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08916939209014632","article-title":"Cytokines and immune regulation in thyroid autoimmunity.","volume":"13","author":"Nagataki","year":"1992","journal-title":"Autoimmunity"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1536\/jhj.41.507","article-title":"Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis.","volume":"41","author":"Inomata","year":"2000","journal-title":"Jpn Heart J"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/hep.30073","article-title":"CD2-associated protein contributes to hepatitis C, virus propagation and steatosis by disrupting insulin signaling.","volume":"68","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"21865","DOI":"10.7448\/IAS.20.1.21865","article-title":"T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy na\u00efve chronic HIV-1 patients.","volume":"20","author":"Bolduan","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2257.2005.00715.x","article-title":"CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.","volume":"27","author":"Kaito","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"R32-20260622","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00428-022-03348-x","article-title":"CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.","volume":"481","author":"Ghosh","year":"2022","journal-title":"Virchows Arch"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"664845","DOI":"10.3389\/fimmu.2021.664845","article-title":"CD2 is a novel immune-related prognostic biomarker of invasive breast carcinoma that modulates the tumor microenvironment.","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"R34-20260622","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12885-017-3982-1","article-title":"Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.","volume":"18","author":"Bernal-Est\u00e9vez","year":"2018","journal-title":"BMC Cancer"},{"key":"R35-20260622","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/nar\/gky1204","article-title":"Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries.","volume":"47","author":"Riemondy","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2164-9-225","article-title":"Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.","volume":"9","author":"Wang","year":"2008","journal-title":"BMC Genomics"},{"key":"R37-20260622","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.compbiomed.2016.07.004","article-title":"CD3D and PRKCQ work together to discriminate between B-cell and T-cell acute lymphoblastic leukemia.","volume":"77","author":"Ma","year":"2016","journal-title":"Comput Biol Med"},{"key":"R38-20260622","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.2008.07037.x","article-title":"Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.","volume":"141","author":"Linderoth","year":"2008","journal-title":"Br J Haematol"},{"key":"R39-20260622","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors.","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"R40-20260622","doi-asserted-by":"crossref","first-page":"BSR20202898","DOI":"10.1042\/BSR20202898","article-title":"Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.","volume":"41","author":"Zhu","year":"2021","journal-title":"Biosci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:02:05Z","timestamp":1782118925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048367","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2025-06-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}